Health X Platform Ltd
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
- Market Cap ₹ 921 Cr.
- Current Price ₹ 290
- High / Low ₹ 375 / 252
- Stock P/E
- Book Value ₹ 201
- Dividend Yield 0.00 %
- ROCE 0.03 %
- ROE 0.44 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company's median sales growth is 36.1% of last 10 years
- Company's working capital requirements have reduced from 44.5 days to 28.3 days
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 2.11% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,375 | 1,468 | |
| 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,371 | 1,534 | |
| Operating Profit | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | 4 | -67 |
| OPM % | -19% | -31% | -15% | -8% | -15% | -13% | -1.9% | 62% | -10% | -1.7% | -1.6% | 0.3% | -4.5% |
| 2 | -0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 1 | 45 | |
| Interest | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 1 | 1 |
| Depreciation | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 7 | 7 |
| Profit before tax | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | -2 | -31 |
| Tax % | -0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | -39% | |
| -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | -1 | -26 | |
| EPS in Rs | -4.68 | -11.51 | -9.00 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.70 | 2.79 | -28.66 | 0.37 | -6.34 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 20% |
| 3 Years: | 9% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 18% |
| 3 Years: | 27% |
| TTM: | -154% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 0% |
| 3 Years: | 2% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -2% |
| 3 Years: | 2% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 609 |
| 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 26 | |
| 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 264 | |
| Total Liabilities | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 930 |
| 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 | |
| CWIP | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 519 |
| 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 294 | |
| Total Assets | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 930 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 | -74 | |
| 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 | 171 | |
| 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 | -80 | |
| Net Cash Flow | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | -0 | -19 | 18 |
| Free Cash Flow | -28 | -18 | -0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 | -89 |
| CFO/OP | 106% | 43% | 17% | 377% | 89% | 133% | 288% | -8% | 104% | -172% | 68% | -1,729% |
Ratios
Consolidated / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 | 2 |
| Inventory Days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 | 44 |
| Days Payable | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 | 26 |
| Cash Conversion Cycle | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 | 20 |
| Working Capital Days | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 | 28 |
| ROCE % | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% | 0% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of employees count |
|
|||||||||
| Retailer Shakti (B2B) revenue as % of healthcare network revenue % |
||||||||||
| Number of retail pharmacies served (Retailer Shakti B2B network) count |
||||||||||
| Number of SKUs / products available count |
||||||||||
| Market share in West Bengal (pharma distribution) % |
||||||||||
| Number of vendors / pharma companies count |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Disclosure Of Voting Results Of The 37Th AGM Of The Company As per Regulation 44 Of The SEBI (LODR) Reg, 2015
- 37th AGM voting results disclosed; all seven resolutions passed on 28 September 2026.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 37th AGM resolutions passed on 28 Sep 2026, including borrowing, security, loans and director reappointments.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Health X Platform held its 37th AGM on 28 September 2026; shareholders considered financials, director appointments and borrowing approvals.
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication regarding Notice of 37th Annual General Meeting and e-voting information.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from nse
-
Annual Report 2013
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT REC
-
Jun 2026PPT
-
Feb 2026Transcript PPT
-
Feb 2026PPT
-
Nov 2025Transcript PPT
-
Aug 2025PPT
-
Jun 2025Transcript PPT
-
Feb 2025PPT
-
Nov 2024Transcript PPT
-
Oct 2024PPT
-
Jun 2024PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023PPT
-
Mar 2023PPT
-
Feb 2023PPT
-
Nov 2022PPT
-
Sep 2022PPT
-
Jun 2022PPT
-
Mar 2022PPT
-
Dec 2021PPT
-
Nov 2021PPT
-
Nov 2021PPT
-
Aug 2021PPT
-
Jun 2021PPT
-
Feb 2021PPT
-
Nov 2020PPT
-
Aug 2018PPT
-
Feb 2018PPT
-
Nov 2017PPT
Business Overview:[1][2][3]
SSVL, a Core Investment Company (CIC), operates through multiple subsidiaries and offers a digital platform for pharmacy, wellness, and diagnostics, serving both B2B and B2C segments with person-centric healthcare solutions.